[go: up one dir, main page]

FI972865A0 - Hydroksimetyyli-imidatsodiatseptiinejä ja niiden esterit - Google Patents

Hydroksimetyyli-imidatsodiatseptiinejä ja niiden esterit

Info

Publication number
FI972865A0
FI972865A0 FI972865A FI972865A FI972865A0 FI 972865 A0 FI972865 A0 FI 972865A0 FI 972865 A FI972865 A FI 972865A FI 972865 A FI972865 A FI 972865A FI 972865 A0 FI972865 A0 FI 972865A0
Authority
FI
Finland
Prior art keywords
esters
hydroxymethylimidazodiazepines
imidazodiazepines
anxiolytic
anticonvulsant
Prior art date
Application number
FI972865A
Other languages
English (en)
Swedish (sv)
Other versions
FI972865L (fi
FI972865A7 (fi
Inventor
Rene Borer
Bernd Buettelmann
Max Gerecke
Andre Szente
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI972865A0 publication Critical patent/FI972865A0/fi
Publication of FI972865L publication Critical patent/FI972865L/fi
Publication of FI972865A7 publication Critical patent/FI972865A7/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02Muscle relaxants, e.g. for tetanus or cramps
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/12Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains three hetero rings
    • C07D495/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI972865A 1995-01-06 1996-01-03 Hydroksimetyyli-imidatsodiatseptiinejä ja niiden esterit FI972865A7 (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH2895 1995-01-06
PCT/CH1996/000001 WO1996020941A1 (de) 1995-01-06 1996-01-03 Hydroxymethyl-imidazodiazepine und deren ester

Publications (3)

Publication Number Publication Date
FI972865A0 true FI972865A0 (fi) 1997-07-04
FI972865L FI972865L (fi) 1997-09-03
FI972865A7 FI972865A7 (fi) 1997-09-03

Family

ID=4177731

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972865A FI972865A7 (fi) 1995-01-06 1996-01-03 Hydroksimetyyli-imidatsodiatseptiinejä ja niiden esterit

Country Status (16)

Country Link
US (1) US6174881B1 (fi)
EP (1) EP0801651B1 (fi)
JP (1) JP3001979B2 (fi)
CN (1) CN1168140A (fi)
AT (1) ATE203026T1 (fi)
AU (1) AU4296196A (fi)
BR (1) BR9606823A (fi)
CA (1) CA2209424A1 (fi)
DE (1) DE59607274D1 (fi)
DK (1) DK0801651T3 (fi)
ES (1) ES2159714T3 (fi)
FI (1) FI972865A7 (fi)
GR (1) GR3036867T3 (fi)
PT (1) PT801651E (fi)
TR (1) TR199700587T1 (fi)
WO (1) WO1996020941A1 (fi)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6444664B1 (en) 1997-04-18 2002-09-03 Nederlandse Organisatie Voor Toegepast - Natuurweten Schappelijk Onderzoek (Tno) Method for controlling the plasma level of lipoproteins to treat alzheimeris disease
EP0875247B1 (en) * 1997-04-18 2003-05-28 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Method for controlling the plasma level of lipoproteins
JP3706307B2 (ja) * 1999-05-12 2005-10-12 エフ.ホフマン−ラ ロシュ アーゲー イミダゾジアゼピン誘導体
US7160880B1 (en) 1999-05-14 2007-01-09 Cenes Limited Short-acting benzodiazepines
TWI232863B (en) * 2001-06-11 2005-05-21 Akzo Nobel Nv Benzoxazepine derivatives
PL367185A1 (en) * 2001-06-14 2005-02-21 Akzo Nobel, N.V. (pyrido/thieno)-[f]-oxazepin-5-one derivatives
SI2081921T1 (sl) 2006-07-10 2011-01-31 Paion Uk Ltd Soli benzodiazepina s kratkotrajnim učinkom ter njihove polimorfne oblike
GB0613693D0 (en) 2006-07-10 2006-08-16 Cenes Ltd Benzodiazepine salts (3)
CN101827597B (zh) 2007-08-20 2013-03-13 伊沃泰克国际有限责任公司 睡眠障碍的治疗
US20090054412A1 (en) * 2007-08-20 2009-02-26 John Alan Kemp Treatment of Sleep Disorders
DK2571503T3 (en) 2010-05-14 2015-04-20 Dana Farber Cancer Inst Inc COMPOSITIONS AND THEIR USE IN THE TREATMENT OF NEOPLASIA, INFLAMMATORY DISEASE AND OTHER DISORDERS
US9301962B2 (en) 2010-05-14 2016-04-05 Baylor College Of Medicine Male contraceptive compositions and methods of use
CA2799403C (en) 2010-05-14 2020-01-21 Dana-Farber Cancer Institute, Inc. Compositions and methods for treating leukemia
EP2450039A1 (en) 2010-11-08 2012-05-09 PAION UK Ltd. Dosing regimen for sedation with CNS 7056 (Remimazolam)
AP2014008084A0 (en) 2012-05-22 2014-11-30 Paion Uk Ltd Compositions comprising shortacting benzodiazepines
CN103012408B (zh) * 2012-11-28 2015-02-04 中国科学院广州生物医药与健康研究院 依匹斯汀的合成方法
AR094963A1 (es) 2013-03-04 2015-09-09 Ono Pharmaceutical Co Reacción de oxidación excelente en el índice de conversión
CA2918910A1 (en) 2013-07-25 2015-01-29 Dana-Farber Cancer Institute, Inc. Inhibitors of transcription factors and uses thereof
EP3066101B1 (en) 2013-11-08 2020-07-29 Dana-Farber Cancer Institute, Inc. Combination therapy for cancer using bromodomain and extra-terminal (bet) protein inhibitors
US10793571B2 (en) 2014-01-31 2020-10-06 Dana-Farber Cancer Institute, Inc. Uses of diazepane derivatives
CN106029653A (zh) 2014-01-31 2016-10-12 达纳-法伯癌症研究所股份有限公司 二氨基嘧啶苯砜衍生物及其用途
MX377534B (es) 2014-02-28 2025-03-10 Tensha Therapeutics Inc Compuestos para usarse en el tratamiento de hiperinsulinemia.
US10266534B2 (en) 2014-06-26 2019-04-23 The Johns Hopkins University Peripherally restricted GABA positive allosteric modulators for the treatment of irritable bowel syndrome and other ailments of the peripheral nervous system
MX2017001756A (es) 2014-08-08 2017-05-30 Dana Farber Cancer Inst Inc Derivados de diazepano y sus usos.
MX2017001757A (es) 2014-08-08 2017-05-30 Dana Farber Cancer Inst Inc Derivados de dihidropteridinona y sus usos.
EA033325B1 (ru) 2014-10-27 2019-09-30 Тэнша Терапеутикс, Инк. Ингибиторы бромодомена
US10702527B2 (en) 2015-06-12 2020-07-07 Dana-Farber Cancer Institute, Inc. Combination therapy of transcription inhibitors and kinase inhibitors
CR20180199A (es) 2015-09-11 2018-05-25 Dana Farber Cancer Inst Inc Acetamida tienotriazolodiazepinas y usos de las mismas
HK1256417A1 (zh) 2015-09-11 2019-09-20 达纳-法伯癌症研究所股份有限公司 氰基噻吩並三唑並二氮雜環庚三烯及其用途
RU2742035C2 (ru) 2015-11-25 2021-02-01 Дана-Фарбер Кэнсер Инститьют, Инк. Бивалентные ингибиторы бромодоменов и пути их применения
BR112018071082A2 (pt) 2016-04-14 2019-02-05 Paion Uk Ltd benzodiazepinas nasais e inaladas oralmente
CN107325101B (zh) * 2017-06-29 2019-03-26 上海合全药物研发有限公司 6-羟甲基-6,7-二氢-5h,9h-咪唑并二氮杂卓-8-羧酸叔丁酯的合成方法
CN113087713B (zh) * 2021-03-29 2022-10-04 中国人民解放军军事科学院军事医学研究院 一类苯并二氮䓬衍生物及其制备方法和用途
USD1017893S1 (en) * 2022-03-03 2024-03-12 Elc Management Llc Cosmetic applicator
USD1023445S1 (en) * 2022-03-03 2024-04-16 Elc Management Llc Cosmetic applicator

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4902794A (en) 1971-04-28 1990-02-20 The Upjohn Company Triazolo-benzodiazepines
US3763179A (en) * 1972-05-05 1973-10-02 Upjohn Co 2-imidazol-1-yl benzophenones
US4280957A (en) 1974-09-11 1981-07-28 Hoffmann-La Roche Inc. Imidazodiazepines and processes therefor
DE2547652A1 (de) * 1974-11-15 1976-05-20 Upjohn Co Pharmazeutische zubereitung
DE3432974A1 (de) 1983-09-12 1985-04-04 The Upjohn Co., Kalamazoo, Mich. Arzneimittel zur prophylaxe oder therapie der negativen shizophreniesymtome bei menschen
DE3435973A1 (de) * 1984-10-01 1986-04-10 Boehringer Ingelheim KG, 6507 Ingelheim Diazepine enthaltende pharmazeutische zusammensetzungen mit paf-antagonistischer wirkung
JP2840454B2 (ja) 1993-11-22 1998-12-24 メルク エンド カンパニー インコーポレーテッド ベンゾジアゼピン類
US5439906A (en) 1993-11-22 1995-08-08 Merck & Co., Inc. Antiarrhythmic benzodiazepines

Also Published As

Publication number Publication date
BR9606823A (pt) 1997-12-30
FI972865L (fi) 1997-09-03
PT801651E (pt) 2001-12-28
US6174881B1 (en) 2001-01-16
ES2159714T3 (es) 2001-10-16
JP3001979B2 (ja) 2000-01-24
GR3036867T3 (en) 2002-01-31
EP0801651B1 (de) 2001-07-11
JPH10500998A (ja) 1998-01-27
AU4296196A (en) 1996-07-24
DK0801651T3 (da) 2001-10-22
CN1168140A (zh) 1997-12-17
MX9705061A (es) 1997-10-31
FI972865A7 (fi) 1997-09-03
DE59607274D1 (de) 2001-08-16
WO1996020941A1 (de) 1996-07-11
EP0801651A1 (de) 1997-10-22
ATE203026T1 (de) 2001-07-15
TR199700587T1 (xx) 1998-02-21
CA2209424A1 (en) 1996-07-11

Similar Documents

Publication Publication Date Title
FI972865A0 (fi) Hydroksimetyyli-imidatsodiatseptiinejä ja niiden esterit
ATE182892T1 (de) Mercaptoacetylamide von pyridazo(1,2-a>(1,2>- diazepin -derivaten als eukephalinase und ace- inhibitoren
DE69619443D1 (de) Ungesättigte Hydroxycarbonsäureverbindungen als Zwischenprodukte zur Herstellung von Schmierstoff- und Kraftstoffadditiven
PT970095E (pt) Novos inibidores benzimidazole de frutose-1,6-bisfosfatase
FI962218A0 (fi) H2-pitoisen kaasun valmistaminen
FI973102A7 (fi) senetelmä modifioitujen aerogeelien valmistamiseksi ja niiden käyttö
FI945434A0 (fi) 4-markatpoasetyyliamino/2/bentsatsepinoni (3) johdannaisia ja niiden käyttö enkefalinaasi-inhibiittoreina
DE69615682D1 (de) N-(1-alkyl-5-phenyl-2,3,4,5-tetrahydro-1-h-benzo[b][1,5]-diazepin-3-yl)-acetamide
DE69317764D1 (de) Aminoacetylmercaptoacetylamid derivate mit enkephalinase- und ace-hemmwirkung
BR9711586A (pt) Compostos e uso dos mesmo
ES2157992T3 (es) Alcoxi-alquil-carbamatos de imidazo(1,2-a)piridinas.
ATE242234T1 (de) Bicyclische arylcarboxamide und ihre therapeutische verwendung
FI963255A7 (fi) Nitrifikaatiota estävät tai säätävät aktiivisten aineiden yhdistelmät
ATE271313T1 (de) Verwendung von pyrrolverbindungen als antifouling-wirkstoff
FI962481A0 (fi) 4-bentsoyyli-isokatsolit ja niiden käyttö herbisideinä
NO960414L (no) Anvendelse av fenylcykloheksylkarboksylsyreamider
FI940999L (fi) Piperidin-2-alkyylikarboksylaattien entsymaattinen toisiintuminen ja saatujen yhdisteiden käyttö synteesin välituotteina
NO952949D0 (no) Forlöpere av anti-inflamatoriske 3-acyl-2-oksindol-1-karboksamider
NO931399D0 (no) Anvendelse av naturstein
DE69430545D1 (de) Verwendung von penciclovir zur behandlung von postherpetischer neuralgie
ES2187656T3 (es) Derivados de acido fosfinico con actividad inhibidora de metalopeptidasa.
ECSP951578A (es) Oxazolyl y thiazolylimidazo- benzo- y thienodiazepines,
KR970025713U (ko) 인라인형 전자총의 전극
DE69427794D1 (de) Verbesserungen an Erdmühlen zur Herstellung von Terrakotta-Produkten
NO953272L (no) Kombinasjoner av retrovirale inhibitorer